Eva N. Hadaschik

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications

Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients.

Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients.

Journal: Frontiers in immunology
Published: October 17, 2025

Cutaneous leukocytoclastic vasculitis as acute hemorrhagic edema in a 71-year-old patient.

Cutaneous leukocytoclastic vasculitis as acute hemorrhagic edema in a 71-year-old patient.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: April 16, 2025

Autoreactive T Follicular Helper Cells Drive Induction of Bullous Pemphigoid-Like Skin Disease.

Autoreactive T Follicular Helper Cells Drive Induction of Bullous Pemphigoid-Like Skin Disease.

Journal: The Journal of investigative dermatology
Published: March 21, 2025

Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series.

Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: March 10, 2025

Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss.

Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: March 10, 2025

pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy.

pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 19, 2024

Recurrent, painful ulcers of the lower extremities and abdomen

Recurrent, painful ulcers of the lower extremities and abdomen

Journal: Dermatologie (Heidelberg, Germany)
Published: September 11, 2024

Early versus late response to PD-1-based immunotherapy in metastatic melanoma.

Early versus late response to PD-1-based immunotherapy in metastatic melanoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2024

Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.

Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 10, 2024

Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signaling.

Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signaling.

Journal: Nature communications
Published: February 06, 2024

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.

Journal: Frontiers in immunology
Published: February 06, 2024

Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab.

Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab.

Journal: Frontiers in immunology
Published: January 11, 2024
Showing 1-12 of 142

Last Updated: 09/26/2026